Is RLMD A Good Stock To Buy Now?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge...
Relmada Therapeutics Inc. (RLMD)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 1,525,000 | $48,907 | +2% | 0.84% |
| 2. | Point72 Asset Management Steve Cohen | 285,000 | $9,140 | +44% | 0.04% |
| 3. | Tang Capital Management Kevin C. Tang | 200,000 | $6,414 | -60% | 0.97% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 178,565 | $5,727 | 3.11% | |
| 5. | Acuta Capital Partners Manfred Yu | 120,000 | $3,848 | -57% | 1.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.00 | 978 | Director | 2,228 | 2019-10-21 | Filing | |
| $19.20 | 3,100 | Director | 127,121 | 2019-10-18 | Filing | |
| $19.15 | 100 | Director | 124,021 | 2019-10-18 | Filing | |
| $19.10 | 200 | Director | 123,921 | 2019-10-18 | Filing | |
| $19.08 | 100 | Director | 123,721 | 2019-10-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.87 | 3,000 | Director | 15,950 | 2021-03-01 | Filing | |
| $35.55 | 303 | Officer, Director | 88,774 | 2021-02-24 | Filing | |
| $34.70 | 4,860 | Officer, Director | 89,077 | 2021-02-24 | Filing | |
| $33.69 | 4,837 | Officer, Director | 93,937 | 2021-02-24 | Filing | |
| $35.58 | 108 | Director | 167,295 | 2021-02-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 6,400 | $205,248 | 0% | |
| 2. | 1,512,673 | $48,511 | 0.81% | |
| 3. | 1,493,019 | $47,882 | 0% | |
| 4. | 668,440 | $21,437 | 3.15% | |
| 5. | 662,623 | $21,250 | 0% |
News See All
Hedge Funds Are Nibbling On Relmada Therapeutics, Inc. (RLMD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings...
Billionaire Hedge Funds
